Press Releases

February 28, 2023
MONTREAL and CHARLOTTE, N.C. , Feb. 28, 2023 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that members of its management team will present at the
Print Page
RSS Feeds
Email Alerts
Investor Contact
Search